Internal Medicine, Pulmonary Disease · Lebanon, TN
NPI
1912989989
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1424 Baddour Pkwy, Suite H
Lebanon, TN, 37087
Phone (615) 444-8686
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,861 services
Medicare patients, 2024
562
Average age 74
Drug cost, 2024
$2.0M
7,078 prescriptions
Company payments, 2023
$13.83
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Modupe O Kehinde was code 99213 (office e&m - established), 559 times for 361 patients. In total Modupe O Kehinde billed 1,861 services in 31 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 559 | 361 | $61.01 | $34K |
| 99214 Office E&M - Established | Office | 373 | 230 | $90.06 | $34K |
| 94729 Pulmonary Function Testing | Office | 134 | 132 | $39.21 | $5,254 |
| 94726 Pulmonary Function Testing | Office | 133 | 131 | $38.58 | $5,131 |
| 94060 Pulmonary Function Testing | Office | 121 | 119 | $26.54 | $3,211 |
| 99203 Office E&M - New | Office | 101 | 101 | $77.09 | $7,786 |
| 99232 Hospital E&M - Subsequent | Facility | 83 | 34 | $57.54 | $4,776 |
| 99204 Office E&M - New | Office | 63 | 63 | $119.03 | $7,499 |
| 99223 Hospital E&M - Initial | Facility | 35 | 34 | $127.35 | $4,457 |
| 99231 Hospital E&M - Subsequent | Facility | 35 | 23 | $36.22 | $1,268 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 31 | 30 | $25.72 | $797 |
| 94729 Pulmonary Function Testing | Facility | 30 | 29 | $6.52 | $196 |
| 94727 Pulmonary Function Testing | Facility | 20 | 20 | $8.84 | $177 |
| 94060 Pulmonary Function Testing | Facility | 20 | 20 | $7.53 | $151 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $95.59 | $1,625 |
By year: 2022 $91K for 1,402 services; 2023 $109K for 1,769 services; 2024 $115K for 1,861 services.
Medicare prescription drug claims, 2024
In 2024, the drug Modupe O Kehinde prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,099 prescriptions and refills. In total Modupe O Kehinde wrote 7,078 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,099 | 1,337 | 348 | $33K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 876 | 1,068 | 172 | $675K |
| Prednisone Generic | 522 | 543 | 260 | $1,189 |
| Breo Ellipta Fluticasone/Vilanterol | 467 | 614 | 90 | $238K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 414 | 595 | 121 | $72K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 349 | 431 | 77 | $194K |
| Montelukast Sodium Generic | 285 | 608 | 75 | $3,124 |
| Arnuity Ellipta Fluticasone Furoate | 227 | 253 | 59 | $51K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 213 | 277 | 45 | $172K |
| Fluticasone Propionate Generic | 204 | 374 | 94 | $2,395 |
| Furosemide Generic | 164 | 236 | 48 | $305 |
| Roflumilast Generic | 163 | 212 | 35 | $17K |
| Azelastine Hcl Generic | 160 | 218 | 64 | $5,015 |
| Spiriva Handihaler Tiotropium Bromide | 129 | 145 | 32 | $73K |
| Advair Hfa Fluticasone Propion/Salmeterol | 124 | 161 | 34 | $55K |
Brand drugs: 3,805 claims; generic drugs: 3,273 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Modupe O Kehinde $13.83 ($13.83 in general payments such as food, travel and fees) from 1 company. The largest payer was Vapotherm Inc with $13.83.
| Company | Payments | Amount |
|---|---|---|
| Vapotherm Inc | 1 | $13.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.